Long-term outcomes in pulmonary arterial hypertension

被引：3
|
作者：
Thenappan, T. [1 ]
Palevsky, H. I. [2 ]
机构：
[1] Univ Chicago, Med Ctr, Dept Med, Cardiol Sect, Chicago, IL 60637 USA
[2] Univ Penn Hlth Syst, Penn Presbyterian Med Ctr, Dept Med, Div Pulm Allergy & Crit Care, Philadelphia, PA USA
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2009年 / 63卷
关键词：
INTRAVENOUS EPOPROSTENOL; SURVIVAL; THERAPY; REGISTRY; ANTICOAGULANT; METAANALYSIS; BOSENTAN; TRIALS;
D O I：
10.1111/j.1742-1241.2009.02128.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：42 / 44
页数：3
相关论文
共 50 条
  • [41] Severe Pediatric Pulmonary Arterial Hypertension. Long-Term Outcomes of Reverse Potts Shunt and Transplantation
    Valdeolmillos, E.
    Le Pavec, J.
    Audie, M.
    Savale, L.
    Jais, X.
    Feuillet, S.
    Sitbon, O.
    Mercier, O.
    Petit, J.
    Humbert, M.
    Fadel, E.
    Belli, E.
    Hascoet, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S11 - S11
  • [42] Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
    Ben-Yehuda, Ori
    Pizzuti, David
    Brown, Andrea
    Littman, Marcus
    Gillies, Hunter
    Henig, Noreen
    Peschel, Tobias
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (01) : 80 - U105
  • [43] Long-Term Ambrisentan Therapy for Pulmonary Arterial Hypertension: Comparison by Etiology
    Pulido, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [44] Long-term continuous subcutaneous treprostinil therapy for pulmonary arterial hypertension
    Skoro-Sajer, N
    Harja, E
    Bonderman, D
    Rezaie-Majd, S
    Machherndl, S
    Kneussl, M
    Lang, MI
    EUROPEAN HEART JOURNAL, 2003, 24 : 483 - 483
  • [45] Long-term experience with implantable treprostinil pumps in pulmonary arterial hypertension
    Dytrych, V
    Kuchar, J.
    Ambroz, D.
    Kunstyr, J.
    Grus, T.
    Lindner, J.
    Linhart, A.
    Jansa, P.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (05): : 358 - 361
  • [46] Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension
    Delcroix, Marion
    Simonneau, Gerald
    Bergot, Emmanuel
    Boonstra, Anco
    Granton, John
    Langleben, David
    Subias, Pilar Escribano
    Galie, Nazzareno
    Pfister, Thomas
    Lemarie, Jean-Christophe
    Sitbon, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [47] Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension
    Kim, NH
    Channick, RN
    Rubin, LJ
    CHEST, 2003, 124 (04) : 1612 - 1615
  • [48] Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients
    Tahara, Nobuhiro
    Dobashi, Hiroaki
    Fukuda, Keiichi
    Funauchi, Masanori
    Hatano, Masaru
    Ikeda, Satoshi
    Joho, Shuji
    Kihara, Yasuki
    Kondo, Takahisa
    Matsushita, Masakazu
    Minamino, Tohru
    Nakanishi, Norifumi
    Okano, Yoshiaki
    Ozaki, Yukio
    Saji, Tsutomu
    Sakai, Satoshi
    Tanabe, Nobuhiro
    Watanabe, Hiroshi
    Yamada, Hidehiro
    Yoshioka, Koichiro
    Hatta, Motonori
    Sasayama, Shigetake
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (06) : 921 - 928
  • [49] Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension
    Speich, Rudolf
    Ulrich, Silvia
    Domenighetti, Guido
    Huber, Lars C.
    Fischler, Manuel
    Treder, Ursula
    Breitenste, Alexander
    RESPIRATION, 2015, 89 (06) : 515 - 524
  • [50] Long-term survival of systemic sclerosis with pulmonary arterial hypertension patients
    Sirijanchune, Piyaporn
    Lhakum, Panomkorn
    RESPIROLOGY, 2023, 28 : 26 - 27
12345